(Q38085336)

English

Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.

scientific article published on March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

multiple sclerosis

0 references

Anthony Traboulsee

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Ellen Lu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bing Wei Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Colleen Guimond

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Anne Synnes

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

A Dessa Sadovnick

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Leanne Dahlgren

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

1 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

251-60; quiz 261

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23448215%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Treatment of multiple sclerosis: current concepts and future perspectives

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Pregnancy and multiple sclerosis: the initial results from a Brazilian database.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Breastfeeding is not related to postpartum relapses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Part 2: evidence evaluation and management of potential or perceived conflicts of interest: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Parenthood and immunomodulation in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

The Brazilian database on pregnancy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Is this patient pregnant? Can you reliably rule in or rule out early pregnancy by clinical examination? .

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Comorbidities amongst patients with multiple sclerosis: a population-based controlled study

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

High frequency of adverse health behaviors in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Do fathers matter? Paternal contributions to birth outcomes and racial disparities

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Paternal factors and low birthweight, preterm, and small for gestational age births: a systematic review

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Interferon-beta mechanisms of action in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Mitoxantrone and cytotoxic drugs' mechanisms of action

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Medications in pregnancy and lactation: part 1. Teratology

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Alterations in drug disposition during pregnancy: implications for drug therapy

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Enrolling pregnant women in research--lessons from the H1N1 influenza pandemic

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Management of epilepsy during pregnancy

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Multiple sclerosis and pregnancy: experience from a nationwide database in Germany

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

The first case of mitoxantrone exposure in early pregnancy.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Assessing walking disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapse

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should Be Treated at the Time of Diagnosis

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Congenital malformations

1 reference

https://api.crossref.org/works/10.1586%2FERN.13.12

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38085336&oldid=1565188466"